{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:17:53Z","timestamp":1790900273236,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.mehy.2008.06.033","type":"journal-article","created":{"date-parts":[[2008,8,17]],"date-time":"2008-08-17T09:22:32Z","timestamp":1218964952000},"page":"657-663","source":"Crossref","is-referenced-by-count":23,"title":["Is ZMP the toxic metabolite in Lesch\u2013Nyhan disease?"],"prefix":"10.1016","volume":"71","author":[{"given":"Jos\u00e9 M.","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2008.06.033_bib1","series-title":"Metabolic basis of inherited disease","first-page":"1007","article-title":"Hypoxanthine guanine phosphoribosyltransferase deficency: the Lesch\u2013Nyhan syndrome and gouty arthritis","author":"Stout","year":"1989"},{"key":"10.1016\/j.mehy.2008.06.033_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awl056","article-title":"Reich SG; Lesch\u2013Nyhan disease international study group. Delineation of the motor disorder of Lesch\u2013Nyhan disease","volume":"129","author":"Jinnah","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2008.06.033_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0165-0173(99)00094-6","article-title":"Lesch\u2013Nyhan disease and the basal ganglia","volume":"32","author":"Visser","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.mehy.2008.06.033_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1289\/ehp.00108s3409","article-title":"Dopamine function in Lesch\u2013Nyhan disease","volume":"108","author":"Nyhan","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.mehy.2008.06.033_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM198111053051902","article-title":"Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch\u2013Nyhan syndrome","volume":"305","author":"Lloyd","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2008.06.033_bib6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.35.6.907","article-title":"Lesch\u2013Nyhan syndrome: CSF neurotransmitter abnormalities","volume":"35","author":"Silverstein","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2008.06.033_bib7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1056\/NEJM199606133342403","article-title":"Presynaptic dopaminergic deficits in Lesch\u2013Nyhan disease","volume":"334","author":"Ernst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2008.06.033_bib8","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1073\/pnas.93.11.5539","article-title":"Dopamine transporters are markedly reduced in Lesch\u2013Nyhan disease in vivo","volume":"93","author":"Wong","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2008.06.033_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.nbd.2007.01.010","article-title":"Basal ganglia dopamine loss due to defect in purine recycling","volume":"26","author":"Egami","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mehy.2008.06.033_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuroscience.2007.10.065","article-title":"Consequences of impaired purine recycling in dopaminergic neurons","volume":"152","author":"Lewers","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2008.06.033_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/nen.0b013e3180515319","article-title":"Multifocal atrophy of cerebellar internal granular neurons in Lesch\u2013Nyhan disease: case reports and review","volume":"66","author":"Del Bigio","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.mehy.2008.06.033_bib12","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI112255","article-title":"Z-nucleotide accumulation in erythrocytes from Lesch\u2013Nyhan patients","volume":"76","author":"Sidi","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2008.06.033_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1542\/peds.46.4.508","article-title":"The urinary excretion of aminoimidazolecarboxamide in the Lesch\u2013Nyhan syndrome","volume":"46","author":"Newcombe","year":"1970","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2008.06.033_bib14","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00001756-200006260-00006","article-title":"Cytosolic 5\u2019-nucleotidase hyperactivity in erythrocytes of Lesch\u2013Nyhan syndrome patients","volume":"11","author":"Pesi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.mehy.2008.06.033_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0306-4522(02)00836-9","article-title":"5\u2032-Aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells","volume":"117","author":"Garcia-Gil","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2008.06.033_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mehy.2004.01.019","article-title":"The biochemical basis of the neurobehavioral abnormalities in the Lesch\u2013Nyhan syndrome: a hypothesis","volume":"63","author":"Neychev","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2008.06.033_bib17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.31.5.786","article-title":"The histidine requirement of the infant","volume":"31","author":"Snyderman","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2008.06.033_bib18","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1093\/jn\/132.11.3340","article-title":"Long-term effects of histidine depletion on whole-body protein metabolism in healthy adults","volume":"132","author":"Kriengsinyos","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2008.06.033_bib19","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1182\/blood-2002-07-2339","article-title":"Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes","volume":"101","author":"Campas","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2008.06.033_bib20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(75)92661-6","article-title":"Immunological observations on patients with Lesch\u2013Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation","volume":"2","author":"Allison","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2008.06.033_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/BJ20070105","article-title":"AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside","volume":"404","author":"Guigas","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.mehy.2008.06.033_bib22","doi-asserted-by":"crossref","first-page":"51783","DOI":"10.1074\/jbc.M407336200","article-title":"Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells","volume":"279","author":"Kweon","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2008.06.033_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1471-4159.2007.04735.x","article-title":"Bioenergetic and oxidative effects of free 3-nitrotyrosine in culture: selective vulnerability of dopaminergic neurons and increased sensitivity of non-dopaminergic neurons to dopamine oxidation","volume":"103","author":"Ma","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2008.06.033_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","article-title":"Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe","volume":"88","author":"Champy","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2008.06.033_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0306-4522(03)00441-X","article-title":"The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism","volume":"121","author":"Lannuzel","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2008.06.033_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<78::AID-JNR8>3.0.CO;2-G","article-title":"Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch\u2013Nyhan syndrome","volume":"53","author":"Yeh","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mehy.2008.06.033_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj20020148","article-title":"Severe pyridine nucleotide depletion in fibroblasts from Lesch\u2013Nyhan patients","volume":"366","author":"Fairbanks","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.mehy.2008.06.033_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.ph.48.030186.002155","article-title":"ATP-driven H+ pumping into intracellular organelles","volume":"48","author":"Rudnick","year":"1986","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.mehy.2008.06.033_bib29","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1471-4159.1993.tb03488.x","article-title":"Brain purines in a genetic mouse model of Lesch\u2013Nyhan disease","volume":"60","author":"Jinnah","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2008.06.033_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0149-7634(85)90043-0","article-title":"The biochemical basis of the behavioral disorder in the Lesch\u2013Nyhan syndrome","volume":"9","author":"Baumeister","year":"1985","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.mehy.2008.06.033_bib31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.mehy.2008.06.033_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(87)80292-2","article-title":"A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis","volume":"223","author":"Carling","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2008.06.033_bib33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.mehy.2008.06.033_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1042\/bst0310162","article-title":"AMP-activated protein kinase, super metabolic regulator","volume":"31","author":"Kemp","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.mehy.2008.06.033_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JMN:17:1:45","article-title":"AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation","volume":"17","author":"Culmsee","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mehy.2008.06.033_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.mehy.2008.06.033_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0014-5793(02)03110-1","article-title":"Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells","volume":"526","author":"Meisse","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2008.06.033_bib38","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1074\/jbc.M705232200","article-title":"Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress","volume":"283","author":"Okoshi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2008.06.033_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI16567","article-title":"The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity","volume":"111","author":"Viollet","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2008.06.033_bib40","doi-asserted-by":"crossref","first-page":"42142","DOI":"10.1074\/jbc.M507607200","article-title":"Nutritional status, cognition, and survival: a new role for leptin and AMP kinase","volume":"280","author":"Dagon","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2008.06.033_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2826.2007.01570.x","article-title":"5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells","volume":"19","author":"Fukuda","year":"2007","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.mehy.2008.06.033_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05828","article-title":"Energy-dependent regulation of cell structure by AMP-activated protein kinase","volume":"447","author":"Lee","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2008.06.033_bib43","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1016\/S0021-9258(18)34001-8","article-title":"Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle. Effects on purine nucleotide synthesis","volume":"257","author":"Sabina","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2008.06.033_bib44","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/S0021-9258(18)88943-8","article-title":"5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells","volume":"260","author":"Sabina","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2008.06.033_bib45","first-page":"1058","article-title":"An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids","volume":"2","author":"Jaeken","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2008.06.033_bib46","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1021\/bi0007268","article-title":"Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis","volume":"39","author":"Wall","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.mehy.2008.06.033_bib47","doi-asserted-by":"crossref","first-page":"14237","DOI":"10.1021\/bi00251a036","article-title":"5-Aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase from human CCRF-CEM leukemia cells: purification, pH dependence, and inhibitors","volume":"33","author":"Szabados","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.mehy.2008.06.033_bib48","doi-asserted-by":"crossref","first-page":"13465","DOI":"10.1074\/jbc.M413347200","article-title":"Evidence for the involvement of cytosolic 5\u2019-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine","volume":"280","author":"Barsotti","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2008.06.033_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11302-006-9009-z","article-title":"Recent advances in structure and function of cytosolic IMP-GMP specific 5\u2019-nucleotidase II (cN-II)","volume":"2","author":"Ipata","year":"2006","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.mehy.2008.06.033_bib50","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.6199843","article-title":"The enzymatic synthesis of 5-amino-4-imidazolecarboxamide riboside triphosphate (ZTP)","volume":"223","author":"Sabina","year":"1984","journal-title":"Science"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708003083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708003083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T10:38:57Z","timestamp":1709203137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987708003083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0306987708003083"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2008.06.033","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}